Lene Hjerrild Iversen
Overview
Explore the profile of Lene Hjerrild Iversen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simoni A, Ahlstrom L, Ording A, Iversen L, Johnsen S, Jensen J, et al.
BMJ Open Qual
. 2025 Jan;
14(1.
PMID: 39755562
Background: The Danish clinical quality registries monitor and improve the quality of care, using quality indicators and defined development targets referred to as 'standards'. This study aims to investigate the...
2.
Lundbech M, Krag A, Iversen L, Brandsborg B, Hvas A
Pleura Peritoneum
. 2024 Dec;
9(4):149-154.
PMID: 39712293
Objectives: Cancer cells can activate coagulation and inhibit fibrinolysis. The aim was to investigate the association between the burden of peritoneal metastases from colorectal cancer (PM-CRC) and biomarkers reflecting thrombin...
3.
Ogaard N, Jensen S, Worm Orntoft M, Demuth C, Heilskov Rasmussen M, Vesterman Henriksen T, et al.
Br J Cancer
. 2024 Oct;
131(10):1707-1715.
PMID: 39390251
Background: Multiple initiatives aim to develop circulating tumour DNA (ctDNA) tests for early cancer detection in asymptomatic individuals. The few studies describing ctDNA-testing in both asymptomatic and symptomatic patients report...
4.
Nielsen M, Ravn S, Sorensen M, Funder J, Iversen L
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339382
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has improved the 5-year survival for colorectal cancer (CRC) patients with peritoneal metastases (PM). Little is known about recurrence patterns and recurrence...
5.
Balachandran R, Sorensen M, Funder J, Knudsen A, Iversen L
Pleura Peritoneum
. 2023 Dec;
8(4):167-174.
PMID: 38144219
Objectives: Peritoneal metastases (PM) and liver metastases (LM) are present simultaneously in up to 2 % of patients at the time of their colorectal cancer (CRC) diagnosis. Curatively intended treatment...
6.
Balachandran R, Thaysen H, Christensen P, Zachariae R, Iversen L
Ann Surg Oncol
. 2023 Dec;
31(3):1959-1969.
PMID: 38127212
Background: Colorectal cancer with peritoneal metastases can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Treatment may result in biopsychosocial late effects (LEs). We explored the frequency and severity...
7.
Ravn S, Gronfeldt J, Thaysen H, Iversen L
Eur J Surg Oncol
. 2023 Dec;
50(1):107105.
PMID: 38096698
Aim: To investigate the impact of the surgical extent on late adverse effects (LAE) following cytoreductive surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Method: A prospective cohort study including patients...
8.
Balachandran R, Thaysen H, Christensen P, Zachariae R, Iversen L
Ann Surg Oncol
. 2023 Dec;
31(3):1696-1697.
PMID: 38071710
No abstract available.
9.
Nors J, Iversen L, Erichsen R, Gotschalck K, Andersen C
JAMA Oncol
. 2023 Nov;
10(1):54-62.
PMID: 37971197
Importance: Management of colorectal cancer (CRC) has been updated continuously over the past 2 decades. While the combination of these initiatives has had implications for improved survival, the implications for...
10.
Valsamidis T, Rasmussen T, Eriksen J, Iversen L
Int J Colorectal Dis
. 2023 Nov;
38(1):265.
PMID: 37935974
Purpose: Anastomotic leakage (AL) after colorectal resection is a serious postoperative complication with grave consequences for patients. Despite several efforts to reduce its incidence, AL is still seen among 2-20%...